Xtant Medical Holdings, Inc. (XTNT) — SEC Filings
Xtant Medical Holdings, Inc. (XTNT) — 23 SEC filings. Latest: 10-K (Mar 31, 2026). Includes 10 8-K, 6 10-Q, 3 10-K.
View Xtant Medical Holdings, Inc. on SEC EDGAR
Overview
Xtant Medical Holdings, Inc. (XTNT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Mar 31, 2026: Xtant Medical Holdings, Inc. reported $18.7 million in license revenue in 2025, primarily from its SimpliMax product, which is not expected to recur in 2026 due to changes in reimbursement effective January 1, 2026. This change will also adversely affect a portion of product revenue and gross margin
Sentiment Summary
Across 23 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 19 neutral, 1 mixed. The dominant filing sentiment for Xtant Medical Holdings, Inc. is neutral.
Filing Type Overview
Xtant Medical Holdings, Inc. (XTNT) has filed 3 10-K, 10 8-K, 6 10-Q, 2 DEF 14A, 1 SC 13D/A, 1 SC 13G/A with the SEC between Feb 2024 to Mar 2026.
Filings by Year
Recent SEC Filings (23)
Risk Profile
Risk Assessment: Of XTNT's 20 recent filings, 1 were flagged as high-risk, 16 as medium-risk, and 3 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | N/A |
| Net Income | N/A |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | N/A |
| Operating Margin | N/A |
| Total Assets | N/A |
| Total Debt | N/A |
Key Executives
- Stavros G. Vizirgianakis
- Sean E. Browne
- Scott C. Neils
Industry Context
Xtant Medical operates in the global medical technology sector, specifically focusing on orthobiologics and spinal implant fixation systems. The market involves companies developing solutions for spinal fusion, trauma, and other orthopedic applications. Key trends include the development of advanced synthetic bone grafts, biologics for wound closure, and innovative fixation systems, alongside strategic acquisitions and distribution network expansion.
Top Tags
financials (5) · filing (4) · 10-Q (4) · SEC Filing (3) · material-definitive-agreement (3) · Medical Technology (2) · Medical Devices (2) · corporate-governance (2) · 10-K (2) · Financials (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| License Revenue | $18.7M | Recognized in 2025, not expected to repeat in 2026 due to reimbursement changes. |
| Coflex/CoFix Divestiture Price | $17.5M | Total purchase price for Coflex/CoFix assets sold to Companion Spine, LLC. |
| Paradigm Divestiture Price | $3.9M | Total purchase price for Paradigm Spine GmbH sold to Companion Spine SAS. |
| Aggregate Divestiture Price | $21.4M | Total proceeds from the sale of Coflex/CoFix assets and Paradigm Spine GmbH. |
| Shares Outstanding | 140,068,260 | As of March 25, 2026. |
| Market Value of Non-Affiliate Common Stock | $45.0M | As of June 30, 2025. |
| Net Income | $4.916M | Nine months ended Sept 30, 2025, compared to -$13.284M loss in prior year. |
| Total Revenue | $101.570M | Nine months ended Sept 30, 2025, an 18.44% increase from $85.754M. |
| Product Revenue | $27.772M | Three months ended Sept 30, 2025, a slight decrease from $27.937M. |
| Gross Profit | $66.519M | Nine months ended Sept 30, 2025, a 27.45% increase from $52.192M. |
| Total Operating Expenses | $58.291M | Nine months ended Sept 30, 2025, a 6.56% decrease from $62.384M. |
| Income from Operations | $8.228M | Nine months ended Sept 30, 2025, a significant improvement from -$10.192M loss. |
| Cash and Cash Equivalents | $10.400M | As of Sept 30, 2025, up from $6.199M at Dec 31, 2024. |
| Advances from Asset Sale | $5.000M | Received from pending sale of Coflex/CoFix assets. |
| Common Shares Outstanding | 140,004,240 | As of November 7, 2025. |
Frequently Asked Questions
What are the latest SEC filings for Xtant Medical Holdings, Inc. (XTNT)?
Xtant Medical Holdings, Inc. has 23 recent SEC filings from Feb 2024 to Mar 2026, including 10 8-K, 6 10-Q, 3 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of XTNT filings?
Across 23 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 19 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Xtant Medical Holdings, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Xtant Medical Holdings, Inc. (XTNT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Xtant Medical Holdings, Inc.?
Key financial highlights from Xtant Medical Holdings, Inc.'s most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for XTNT?
The investment thesis for XTNT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Xtant Medical Holdings, Inc.?
Key executives identified across Xtant Medical Holdings, Inc.'s filings include Stavros G. Vizirgianakis, Sean E. Browne, Scott C. Neils.
What are the main risk factors for Xtant Medical Holdings, Inc. stock?
Of XTNT's 20 assessed filings, 1 were flagged high-risk, 16 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Xtant Medical Holdings, Inc.?
Forward guidance and predictions for Xtant Medical Holdings, Inc. are extracted from SEC filings as they are enriched.